ALKS Form 3 Filed — Joshua Reed Identified as CFO, No Beneficial Ownership

Rhea-AI Filing Summary

Joshua Reed, Senior Vice President and Chief Financial Officer of Alkermes plc (ticker ALKS), submitted an initial Form 3 reporting his relationship to the issuer and stating that no securities are beneficially owned as of the reported event date. The filing cites the event date of 09/15/2025 and is signed on behalf of Mr. Reed by an attorney-in-fact, Shantale Greenson, on 09/23/2025. The form includes an exhibit listing a Power of Attorney (Exhibit 24.1) and contains standard Section 16(a) reporting information without disclosure of any direct or indirect holdings or derivative positions.

Positive

• Initial Form 3 filed identifying Joshua Reed's officer role at Alkermes plc
• Statement that no securities are beneficially owned, providing clarity on current insider holdings
• Power of Attorney (Exhibit 24.1) included, documenting authorized signing authority

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine initial Section 16 filing; discloses officer status and reports no beneficial ownership.

The Form 3 is a standard initial disclosure identifying Mr. Joshua Reed as SVP and Chief Financial Officer of Alkermes plc and confirms there are no non-derivative or derivative securities reported as beneficially owned. From a governance perspective, timely filing of an initial Form 3 fulfills Section 16(a) disclosure obligations and the included Power of Attorney exhibit documents the attorney-in-fact signature authority. There are no ownership details to assess alignment with insider interests or potential conflicts.

Securities Analyst

TL;DR: Informational filing only; contains no holdings or transactions to affect investor valuation.

This Form 3 provides identification and role information for an officer but reports no beneficial ownership of ALKS securities as of the event date. There are no reported transactions, holdings, or derivative positions to evaluate for market impact. The filing is informational and does not provide metrics or material changes relevant to financial analysis.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Reed Joshua

(Last) (First) (Middle)

900 WINTER ST.

(Street)

WALTHAM MA 02451

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/15/2025

3. Issuer Name and Ticker or Trading Symbol
Alkermes plc. [ ALKS ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

EXHIBIT LIST: Exhibit 24.1 - Power of Attorney

No securities are beneficially owned.

	/s/ Shantale Greenson, attorney-in-fact for Joshua Reed	09/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the Form 3 filed for ALKS by Joshua Reed disclose?

The Form 3 identifies Joshua Reed as SVP and Chief Financial Officer of Alkermes plc and states no securities are beneficially owned as of 09/15/2025.

When is the event date reported on Joshua Reed's Form 3 for ALKS?

The event date reported on the Form 3 is 09/15/2025.

Was the Form 3 for ALKS signed by Joshua Reed directly?

No; the filing is signed by an attorney-in-fact, Shantale Greenson, on behalf of Joshua Reed on 09/23/2025.

Does the Form 3 disclose any derivative or non-derivative holdings for ALKS?

No; the Form 3 explicitly states no securities are beneficially owned and lists no derivative or non-derivative holdings.

Is there any exhibit attached to Joshua Reed's Form 3 for ALKS?

Yes; the filing lists Exhibit 24.1, a Power of Attorney.